1100215-54-0Relevant articles and documents
HETEROCYCLIC COMPOUND
-
, (2016/04/08)
The present invention relates to a compound represented by the formula (I), which is useful as an agent for the prophylaxis or treatment of epilepsy, neurodegenerative disease and the like. In the formula (I), each symbol is as defined in the specification.
Substituted Heterocyclic Ethers and Their Use in CNS Disorders
-
Page/Page column 85, (2009/01/24)
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.